{"title":"Genetic characterization of an ABO*O.01.02-A2.05 hybrid allele associated with the Ael phenotype in a Chinese individual","authors":"Shuang Liang, Yan-Lian Liang, Fan Wu, Tong Liu, Li-Yan Sun, Qiong Yu","doi":"10.1016/j.transci.2025.104211","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Discrepancies in ABO typing can arise from genetic variations, posing risks in transfusions. Traditional sequencing handles point mutations well but struggles with recombination events, which long-read sequencing can accurately identify. Here, we report a case of A<sub>el</sub> phenotype associated with a novel recombination allele in the <em>ABO</em> gene in a Chinese individual.</div></div><div><h3>Study design and methods</h3><div>We used serological methods to identify the phenotype, and applied sequencing-based typing (SBT) and third-generation long-read sequencing (TGS) to determine the <em>ABO</em> genotype.</div></div><div><h3>Results</h3><div>Serological testing revealed an A<sub>el</sub> subtype. SBT sequencing identified seven heterozygous mutation sites, with one allele hypothesized as <em>ABO*O.01.01</em> (c.261delG). The remaining six variants did not match any known allele combination. Two <em>ABO</em> haplotype sequences were obtained through TGS. Analysis confirmed a second haplotype as a hybrid of <em>O.01.02-A02.05</em>, with the breakpoint located between c.220C>T (g.chr9: 133258116C>T; p.Pro74Ser) and c.239+103delCCC (g.chr9: 133257993delCCC) . The novel allele sequence has been submitted to GenBank (Accession number: OR2834978).</div></div><div><h3>Conclusion</h3><div>Our study demonstrates a case of a Chinese individual with an A<sub>el</sub> phenotype caused by a novel allele resulting from the recombination of <em>O.01.02</em> and <em>A2.05</em>. This finding underscores the significant advantage of long-read TGS technology in resolving structural variations.</div></div>","PeriodicalId":49422,"journal":{"name":"Transfusion and Apheresis Science","volume":"64 5","pages":"Article 104211"},"PeriodicalIF":1.2000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion and Apheresis Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1473050225001491","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Discrepancies in ABO typing can arise from genetic variations, posing risks in transfusions. Traditional sequencing handles point mutations well but struggles with recombination events, which long-read sequencing can accurately identify. Here, we report a case of Ael phenotype associated with a novel recombination allele in the ABO gene in a Chinese individual.
Study design and methods
We used serological methods to identify the phenotype, and applied sequencing-based typing (SBT) and third-generation long-read sequencing (TGS) to determine the ABO genotype.
Results
Serological testing revealed an Ael subtype. SBT sequencing identified seven heterozygous mutation sites, with one allele hypothesized as ABO*O.01.01 (c.261delG). The remaining six variants did not match any known allele combination. Two ABO haplotype sequences were obtained through TGS. Analysis confirmed a second haplotype as a hybrid of O.01.02-A02.05, with the breakpoint located between c.220C>T (g.chr9: 133258116C>T; p.Pro74Ser) and c.239+103delCCC (g.chr9: 133257993delCCC) . The novel allele sequence has been submitted to GenBank (Accession number: OR2834978).
Conclusion
Our study demonstrates a case of a Chinese individual with an Ael phenotype caused by a novel allele resulting from the recombination of O.01.02 and A2.05. This finding underscores the significant advantage of long-read TGS technology in resolving structural variations.
期刊介绍:
Transfusion and Apheresis Science brings comprehensive and up-to-date information to physicians and health care professionals involved in the rapidly changing fields of transfusion medicine, hemostasis and apheresis. The journal presents original articles relating to scientific and clinical studies in the areas of immunohematology, transfusion practice, bleeding and thrombotic disorders and both therapeutic and donor apheresis including hematopoietic stem cells. Topics covered include the collection and processing of blood, compatibility testing and guidelines for the use of blood products, as well as screening for and transmission of blood-borne diseases. All areas of apheresis - therapeutic and collection - are also addressed. We would like to specifically encourage allied health professionals in this area to submit manuscripts that relate to improved patient and donor care, technical aspects and educational issues.
Transfusion and Apheresis Science features a "Theme" section which includes, in each issue, a group of papers designed to review a specific topic of current importance in transfusion and hemostasis for the discussion of topical issues specific to apheresis and focuses on the operators'' viewpoint. Another section is "What''s Happening" which provides informal reporting of activities in the field. In addition, brief case reports and Letters to the Editor, as well as reviews of meetings and events of general interest, and a listing of recent patents make the journal a complete source of information for practitioners of transfusion, hemostasis and apheresis science. Immediate dissemination of important information is ensured by the commitment of Transfusion and Apheresis Science to rapid publication of both symposia and submitted papers.